Browse > Article
http://dx.doi.org/10.3746/jkfn.2005.34.6.743

Effects of Phytoestrogen on Cell Growth and Insulin-like Growth Factor-I (IGF-I) Production in MC3T3-El Cells  

Kwon, Ji-Young (South Sea Fisheries Research Institute, NFRDI)
Nam, Taek-Jeong (Divison of Food Sciences and Biotechnology, Pukyong National University)
Publication Information
Journal of the Korean Society of Food Science and Nutrition / v.34, no.6, 2005 , pp. 743-749 More about this Journal
Abstract
Estrogen is known to play an important role in maintaining bone mass, since the concentration of serum estrogen decrease after menopause and the estrogen deficiency results in bone loss. Phytoestrogens are plant compounds with estrogen-like biological activity, In this study, to investigate the bioactivities of phytoestrogen, which act on bone metabolism, we examined the effect of selected food-borne phytoestrogens (genistein, daidzein and resveratrol) on osteoblast proliferation and IGF-I production using MC3T3-El cells, a mouse calvaria osteoblast-like cell line. Cells were cultured in a serum free medium for 48 hr in the presence of genistein $(10^{-5}\;M)$, daidzein $(10^{-5}\;M)$ and resveratrol $(10^{-5}\;M)$. The effects of genistein, daidzein and resveratrol on the cell proliferation and growth were evaluated by total cell numbers, MTS assay and cell migration assay. Their effect was compared with the $17\beta-estradiol$. Genistein, daidzein and resveratrol exhibited stimulatory effects on the growth of MC3T3-El cells, and the most pronounced effect was shown with daidzein. In addition, these phytoestrogen increased alkaline phosphatase activity of MC3T3-El cells. These effects were similar to that of $17\beta-estradiol$ effects. Moreover, treatment with genistein, daidzein and resveratrol increased production of insulin like growth factor-I (IGF-I) in conditioned media, indicating that the growth promoting effects of these phytoestrogen were related to the changes in production of IGF-I by MC3T3-El cells. These results show that genistein, daidzein and resveratrol have a stimulatory effect on osteoblast function, and that these findings in a cell model may prove relevant to protecting against the loss of bone mass and the development of osteoporosis in human subjects.
Keywords
genistein; daidzein; resveratrol; IGF-I; MC3T3-El;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Shils ME, Young VR. 1988. Modern nutrition in health and disease. 7th ed. Lea and Febiger Publisher, Philadelphia. p 763
2 Christenson RH. 1997. Biochemical markers of bone metabolism: an overview. Clin Biochem 30: 573-593   DOI   ScienceOn
3 Prestwood KM, Pilbeam CC, Raisz LG. 1995. Treatment of osteoporosis. Annu Rev Med 46: 249-256   DOI   ScienceOn
4 Anderson JJ, Garner SC. 1998. Phytoestrogen and bone. Baillieres Clin Endocrinol Metab 12: 543-557   DOI   ScienceOn
5 Lindsay R. 1993. Pathogenesis of postmenopausal osteoporosis. Baillieres Clin Rheumato 7: 499-513   DOI   ScienceOn
6 Gallagher JC, Bishop CW, Knutson JC, Mazess RB, DeLuca HF. 1994. Effects of increasing doses of 1 alpha-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women. J Bone Miner Res 9: 607-614
7 Ettinger B, Genant HK, Cann CE. 1985. Long-term estrogen replacement therapy prevents bone loss and fracture. Ann Intern Med 102: 319-324   DOI   ScienceOn
8 Edward MW, Bain SD, Bailey MC, Lantry MM, Howard GA. 1992. 17$\beta$-estradiol stimulation of endosteal bone formation in the ovariectomized mouse: an animal model for evaluation of bone targeted estrogens. Bone 13: 29-34   DOI   ScienceOn
9 Ernst M, Heath JK, Rodan GA. 1989. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125: 825-833   DOI   ScienceOn
10 McCarthy TL, Centrella M. 1993. Regulation of IGF activity in bone. Adv Exp Med Bio 343: 407-414
11 Genant HK, Baylink DJ, Gallagher JC. 1989. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161: 1842-1846   DOI   ScienceOn
12 Murphy LJ, Ghahary A. 1990. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocrine Rev 11: 443-453   DOI   ScienceOn
13 Anderson JJ, Garner SC 1998. Phytoestrogen and bone. Baillieres Clin Endocrinol Metab 12: 543-557   DOI   ScienceOn
14 Adlercreutz H, Mazur W. 1997. Phyto-oestrogens and Western diseases. Ann Med 29: 95-120   DOI   ScienceOn
15 Setchell KDR. 1998. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68: 1333-1346   DOI
16 Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. 1999. Health potential of soy isoflavones for menopausal women. Public Health Nut 2: 489-504
17 Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ. 2001. Soy bean ethanol extract increases the function of osteoblastic MC3T3-El cells. Phytochemistry 56: 733-739   DOI   ScienceOn
18 Gehm BD, McAndrews JM, Chien PY, Jameson JL. 1997. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94: 14138-14143
19 Setchell KDR, Cassidy A. 1999. Dietary isoflavones: biological effects and relevance to human health. J Nutr 129: 758-767   DOI
20 Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja Sc. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167   DOI
21 Panti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH. 1998 The phytoestrogen genistein reduces bone loss in short-term ovariactomized rats. Osteoporo Int 8: 274-281   DOI   ScienceOn
22 Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167   DOI
23 Mizutani K, Ikeda K, Kawai Y, Yamori Y. 1998. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-El cells. Biochem Biophys Res Commun 253: 859-863   DOI   ScienceOn
24 Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaly S, Davicco MJ, Lebecque P, Barlet JP. 2000. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 130: 1675-1681
25 Ljunghall S, Lindh E. 1989. Assesment of bone turnover with biochemical makers. J Intern Med 225: 219-220   DOI   ScienceOn
26 Sugimoto E, Yamaguchi M. 2000a. Anabolic effect of genistein in osteoblastic MC3T3-El cells. Int J Mol Med 5: 515-520
27 Sugimoto E, Yamaguchi M. 2000b. Stimulatory effect of daidzein in osteoblastic MC3T3-El cells. Biochem Pharmacol 59: 471-475   DOI   ScienceOn
28 Ernst M, Rodan GA. 1991. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 8: 1081-1089
29 Tomkinson A, Reeve J, Shaw RW, Noble BS. 1997. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 3128-3135   DOI   ScienceOn
30 Nasu M, Sugimoto T, Kaji H, Chihara K. 2000. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cell: role of insulin like growth factor (IGF)-I and IGF-binding prtein-5. J Endocrinol 167: 305-313   DOI   ScienceOn
31 Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. 1990. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption and bone loss at tissue and cellular levels. J Bone Miner Res 5: 311-319   DOI   ScienceOn
32 Vedi S, Purdie DW, Ballard P, Bord S. Cooper AC, Compston JE. 1999. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Osteoporos Int 10: 52-58   DOI   ScienceOn
33 Wlodarski KH, Reddi AH. 1986. Alkaline phosphatase as a marker of osteoinductive cells. Calcif Tissue Int 39: 382-385   DOI   ScienceOn
34 Lazowski D, Fraher L, Hodsman A, Steer B, Modrowski D, Han V. 1994. Regional variation of insulin like growth factor-I gene expression in mature rat bone and cartilage. Bone 15: 563-576   DOI   ScienceOn
35 Shinar DM, Endo N, Halperin D, Rodan GA, Weinreb M. 1993. Differential expression of insulin-like growth factor-1 (IGF-I) and IGF-II messenger ribonucleic acid in rowin rat bone. Endocrinology 132: 1158-1167   DOI   ScienceOn
36 Gao YH, Yamaguchi M. 1999. Anabolic effect of daidzein on cortical in tissue culture: Comparison with genistein effect. Mol Cell Biochem 194: 93-98   DOI   ScienceOn
37 Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. 1998. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: 1375-1379   DOI
38 Huynh H. 1998. Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor 1. Int J Oncol 12: 427-432